Valeant Shares Down 37% since August; More Pain Ahead?

Shares of Valeant PharmaceuticalsVRX have plummeted around 37% in the last two months. The downtrend was particularly steep in September after Democratic presidential candidate Hillary Clinton commented on the rising prices of specialty drugs that led to a massive